Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial

  • Horng H. Chen
  • , Kevin J. Anstrom
  • , Michael M. Givertz
  • , Lynne W. Stevenson
  • , Marc J. Semigran
  • , Steven R. Goldsmith
  • , Bradley A. Bart
  • , David A. Bull
  • , Josef Stehlik
  • , Martin M. LeWinter
  • , Marvin A. Konstam
  • , Gordon S. Huggins
  • , Jean L. Rouleau
  • , Eileen O'Meara
  • , W. H.Wilson Tang
  • , Randall C. Starling
  • , Javed Butler
  • , Anita Deswal
  • , G. Michael Felker
  • , Christopher M. O'Connor
    • Raphael E. Bonita, Kenneth B. Margulies, Thomas P. Cappola, Elizabeth O. Ofili, Douglas L. Mann, Victor G. Dávila-Román, Steven E. McNulty, Barry A. Borlaug, Eric J. Velazquez, Kerry L. Lee, Monica R. Shah, Adrian F. Hernandez, Eugene Braunwald, Margaret M. Redfield

Research output: Contribution to journal › Article › peer-review

440   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases